{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:36:46Z","timestamp":1791419806421,"version":"4.3.3"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaci.2020.01.031","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T11:03:28Z","timestamp":1580555008000},"page":"1708-1710.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Treatment of severe lichen planus with the JAK inhibitor tofacitinib"],"prefix":"10.1016","volume":"145","author":[{"given":"William","family":"Damsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Olamiju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjela","family":"Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.01.031_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaad.2019.04.027","article-title":"Clinical epidemiology and treatment of lichen planus: a retrospective review of 2 tertiary care centers","volume":"81","author":"Schwager","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.01.031_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7561","article-title":"IFN-gamma enhances cell-mediated cytotoxicity against keratinocytes via JAK2\/STAT1 in lichen planus","volume":"11","author":"Shao","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2020.01.031_bib3","doi-asserted-by":"crossref","first-page":"e12656","DOI":"10.1111\/dth.12656","article-title":"Tofacitinib for the treatment of lichen planopilaris: a case series","volume":"31","author":"Yang","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2020.01.031_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mehy.2016.04.042","article-title":"Targeting the IFN-gamma\/CXCL10 pathway in lichen planus","volume":"92","author":"Di Lernia","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jaci.2020.01.031_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.01.031_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2133.2007.08106.x","article-title":"A\u00a0scoring system for mucosal disease severity with special reference to oral lichen planus","volume":"157","author":"Escudier","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920301202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920301202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:25:43Z","timestamp":1758792343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920301202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0091674920301202"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.01.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of severe lichen planus with the JAK inhibitor tofacitinib","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}